Cell Therapy, Cannabinoid Biotechs Go Public For $171M
Cell therapy developer Talaris Therapeutics Inc. and cannabinoid biotech Anebulo started trading Friday after raising a combined $171 million in their initial public offerings with help from four law firms....To view the full article, register now.
Already a subscriber? Click here to view full article